RESUMO
Objective: This study assessed the association between erectile dysfunction (ED) and arthritis. Methods: Weighted logistic regression and subgroup analyses were used to investigate the association between arthritis incidence and ED among participants in the 2001-2004 National Health and Nutrition Examination Survey database. Results: Among the participants, 27.8% and 18.5% had a self-reported history of ED and arthritis, respectively. ED was associated with arthritis (odds ratio [OR]=4.00; 95% confidence interval [CI]: 3.20-4.99; p<0.001], which remained significant after adjustment (OR=1.42, 95% CI: 1.00-1.96; p<0.001). Stratified by type of arthritis, after full adjustment, osteoarthritis remained significant (OR=1.11; 95% CI: 1.03-1.20; p=0.017), and rheumatoid arthritis (OR=1.03, 95% CI: 0.93-1.13; p= 0.5) and other arthritis (OR=1.04, 95% CI: 0.98-1.11; p=0.2) were not significantly correlated with ED. Multiple inference analyses confirmed the robustness of the results. Conclusion: Our study showed that arthritis was strongly associated with ED. There is an urgent need to raise awareness and conduct additional research on the reasons behind this association in order to implement more scientific and rational treatment programs for patients with ED and arthritis.
Assuntos
Disfunção Erétil , Inquéritos Nutricionais , Humanos , Masculino , Disfunção Erétil/epidemiologia , Disfunção Erétil/complicações , Disfunção Erétil/etiologia , Pessoa de Meia-Idade , Adulto , Fatores de Risco , Artrite/epidemiologia , Artrite/complicações , Idoso , Incidência , Estados Unidos/epidemiologia , Estudos TransversaisRESUMO
BACKGROUND: Previous research has underscored the correlation between Alzheimer's disease (AD) and erectile dysfunction (ED). However, due to inherent limitations of observational studies, the causative relationship remains inconclusive. METHODS: Utilizing publicly available data from genome-wide association studies (GWAS) summary statistics, this study probed the potential causal association between AD and ED using univariate Mendelian randomization (MR). Further, the multivariable MR assessed the confounding effects of six cardiovascular diseases (CVDs). The primary approach employed was inverse variance weighted (IVW), supplemented by three additional methods. A series of sensitivity analyses were conducted to ensure the robustness of the results. RESULTS: In the forward MR analysis, the IVW method revealed causal evidence of genetically predicted AD being a risk factor for ED (OR = 1.077, 95% CI 1.007â¼1.152, P = 0.031). Reverse analysis did not demonstrate any causal evidence linking ED to AD (OR = 1.018, 95% CI 0.974â¼1.063, P = 0.430). Multivariable MR analysis showed that after adjusting for coronary heart disease (OR = 1.082, 95% CI 0.009â¼1.160, P = 0.027), myocardial infarction (OR = 1.085, 95% CI 1.012â¼1.163, P = 0.022), atrial fibrillation (OR = 1.076, 95% CI 1.002â¼1.154, P = 0.043), heart failure (OR = 1.103, 95% CI 1.024â¼1.188, P = 0.010), ischemic stroke (OR = 1.079, 95% CI 1.009â¼1.154, P = 0.027), hypertension (OR = 1.092, 95% CI 1.011â¼1.180, P = 0.025), and all models (OR = 1.115, 95% CI 1.024â¼1.214, P = 0.012), the causal association between AD and ED persisted. Sensitivity analyses confirmed the absence of pleiotropy, heterogeneity, and outliers, validating the robustness of our results (P > 0.05). CONCLUSIONS: This MR study consistently evidences a causal effect of genetically predicted AD on the risk of ED, independent of certain CVDs, yet offers no evidence for a reverse effect from ED.
Assuntos
Doença de Alzheimer , Doenças Cardiovasculares , Disfunção Erétil , Estudo de Associação Genômica Ampla , Análise da Randomização Mendeliana , Humanos , Masculino , Doença de Alzheimer/genética , Doença de Alzheimer/complicações , Disfunção Erétil/genética , Disfunção Erétil/complicações , Doenças Cardiovasculares/genética , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/complicações , Fatores de Risco , Polimorfismo de Nucleotídeo ÚnicoRESUMO
OBJECTIVES: This cross-sectional study aimed to compare the sexual function (SF) and pelvic floor function of men with systemic sclerosis (SSc) with age-matched healthy controls (HC) and to identify the implications of clinical features on SF. MATERIAL AND METHOD: Twenty SSc males and 20 HC aged 18-70 years completed eleven questionnaires assessing SF [International Index of Erectile Function (IIEF), Male Sexual Health Questionnaire (MSHQ)]; sexual quality of life: Sexual Quality of Life Questionnaire-Male (SQoL-M); pelvic floor function: Pelvic Floor Impact Questionnaire-Short Form 7 (PFIQ-7), fatigue, depression, physical fitness, functional disability, and quality of life. Clinical data were collected. RESULTS: Significantly worse SF was observed in patients (median IIEF erectile function 12 in SSc versus 29 in HC, p < 0.001), with 70% reporting erectile dysfunction (ED) compared to 15% in HC. However, no significant difference was observed regarding pelvic floor function (median PFIQ7 8.8 in SSc versus 7.0 in HC, p = 0.141). Impaired SF was associated with higher disease activity, increased systemic inflammation, more pronounced fatigue, reduced physical fitness, severe depression, impaired overall quality of life, dyspepsia, and arthralgias (p < 0.05 for all). CONCLUSIONS: Sexual dysfunction is highly prevalent in our SSc patients, whereas pelvic floor dysfunction is unlikely to be associated with these problems.
Assuntos
Disfunção Erétil , Escleroderma Sistêmico , Disfunções Sexuais Fisiológicas , Humanos , Masculino , Disfunção Erétil/complicações , Estudos Transversais , Qualidade de Vida , Diafragma da Pelve , Disfunções Sexuais Fisiológicas/etiologia , Escleroderma Sistêmico/complicações , Inquéritos e QuestionáriosRESUMO
Background and Objectives: The significant prevalence of Lower Urinary Tract Symptoms (LUTS), erectile dysfunction (ED), and associated adverse effects calls for increased attention in primary care settings. In Greece, there is a lack of sufficient data for LUTS and ED screening in primary care. Therefore, the aim of our study was to estimate the prevalence of LUTS and ED, identify associated risk factors, and evaluate their impact on quality of life among adult primary healthcare users aged 40 years and older in Crete, Greece. Materials and Methods: A cross-sectional study was conducted to explore the prevalence of LUTS and ED in 1746 primary health care users visiting rural primary health care practices in Crete, Greece. Participants underwent a comprehensive evaluation including demographic parameters, screening for LUTS utilizing the validated International Prostate Symptoms Score (IPSS) questionnaire and for ED using the International Index of Erectile Function (IIEF-5), in males, and for urinary incontinence in women with the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). Participants with a prior diagnosis of LUTS or ED were excluded (n = 183). Results: Out of 536 participants finally included (n = 1746 screened), 32% of males and 36% of females exhibited moderate to severe LUTS. Following adjustments, we identified advanced age, retirement, and the presence of diabetes type 2 as factors associated with the occurrence of LUTS in men. Patients with LUTS also had a substantially increased likelihood of experiencing ED. Moreover, it was observed that women with hypertension or diabetes type 2 and lower education levels face an increased likelihood of developing LUTS, which adversely affects their quality of life. Conclusions: In conclusion, the findings of this study reveal a high occurrence of LUTS and ED in adults aged 40 years and older who utilize primary healthcare services, with a negative impact on their quality of life.
Assuntos
Diabetes Mellitus Tipo 2 , Disfunção Erétil , Sintomas do Trato Urinário Inferior , Incontinência Urinária , Masculino , Adulto , Humanos , Feminino , Pessoa de Meia-Idade , Grécia/epidemiologia , Qualidade de Vida , Estudos Transversais , Disfunção Erétil/epidemiologia , Disfunção Erétil/complicações , Incontinência Urinária/epidemiologia , Incontinência Urinária/complicações , Sintomas do Trato Urinário Inferior/epidemiologia , Sintomas do Trato Urinário Inferior/complicações , Diabetes Mellitus Tipo 2/complicações , Atenção Primária à SaúdeRESUMO
PURPOSE: Erectile dysfunction (ED) is considered a microvascular disorder and serves as an indicator for the potential development of cardiovascular disease (CVD). Although left ventricular diastolic dysfunction (LVDD) reflects early myocardial damage caused by microvascular disorders, the association between ED and LVDD remains poorly elucidated. MATERIALS AND METHODS: A cross-sectional study was conducted on 123 patients with ED. They underwent RigiScan, and conventional echocardiography, and attempted International Index of Erectile Function (IIEF) questionnaire. ED severity was evaluated by measuring changes in the penile base circumference and duration of penile rigidity (≥70%) during erection. The early diastolic velocity of mitral inflow (E) and early diastolic velocity of the mitral annulus (e') were measured using echocardiography. The patients were grouped based on the presence of CVD. RESULTS: Among 123 patients, 29 had CVD and 94 did not. Patients with CVD exhibited more pronounced ED and more severe LVDD. Associations between increased penile circumference with echocardiographic parameters were more prominent in patients with CVD than in those without CVD (ΔTtop and e' wave, r=0.508 and r=0.282, respectively, p for interaction=0.033; ΔTbase and E/e' ratio, r=-0.338 and r=-0.293, respectively, p for interaction <0.001). In the multivariate linear regression, the increase of penile base circumference was an independent risk factor for LVDD (e', B=0.503; E/e' ratio, B=-1.416, respectively, p<0.001). CONCLUSIONS: ED severity correlated well with LV diastolic dysfunction, particularly in the presence of CVD. This study highlighted the potential role of ED assessment as early indicator of CVD development.
Assuntos
Doenças Cardiovasculares , Disfunção Erétil , Disfunção Ventricular Esquerda , Masculino , Humanos , Disfunção Erétil/complicações , Doenças Cardiovasculares/complicações , Estudos Transversais , Disfunção Ventricular Esquerda/complicações , Disfunção Ventricular Esquerda/diagnóstico por imagem , Fatores de RiscoRESUMO
OBJECTIVE: To determine burden and identify correlates of erectile dysfunction (ED) among men with prediabetes (PreD) and type 2 diabetes (T2D) enrolled in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS). RESEARCH DESIGN AND METHODS: The 2017 DPPOS visit included administration of the International Index of Erectile Function. Of 648 male participants, 88 % (n = 568) completed the survey. Associations between sociodemographic, behavioral, clinical, and glycemic measures at time of ED assessment, and ED were examined using multivariable logistic regression models in men with PreD and T2D separately. RESULTS: Overall, 218 (38 %) men met ED criteria. Prevalence was similar in men with PreD (41 %) and T2D (37 %) (p = 0.4). In all men, age (p < 0.001) increased odds of ED. Among men with PreD, those assigned to intensive lifestyle intervention (ILS), but not metformin, had decreased odds of ED compared with the placebo group (OR = 0.35, 95 % CI = 0.13, 0.94). Non-Hispanic White race was associated with increased odds of ED compared with other races (OR = 4.3; 95 % CI = 1.92, 9.65). Among men with T2D, ED risk did not differ by DPP treatment assignment; however, individuals with metabolic syndrome defined by National Cholesterol Education Program criteria, had increased odds of ED (OR = 1.85, 95 % CI = 1.14, 3.01), as did individuals with depression (OR = 2.05; 95 % CI = 1.10, 3.79). CONCLUSIONS: ED is prevalent in men with PreD and T2D. Our finding of reduced odds of ED in men randomized to ILS and with PreD suggests a potential opportunity for risk mitigation in the prediabetes interval. In men who have progressed to T2D, metabolic factors appear to be associated with ED.
Assuntos
Diabetes Mellitus Tipo 2 , Disfunção Erétil , Síndrome Metabólica , Estado Pré-Diabético , Masculino , Humanos , Feminino , Disfunção Erétil/complicações , Disfunção Erétil/epidemiologia , Disfunção Erétil/prevenção & controle , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/epidemiologia , Diabetes Mellitus Tipo 2/prevenção & controle , Estado Pré-Diabético/complicações , Estado Pré-Diabético/epidemiologia , Estado Pré-Diabético/terapia , Prevalência , Síndrome Metabólica/complicações , Fatores de RiscoRESUMO
BACKGROUND: Phosphodiesterase-5 inhibitor (PDE5i) treatment for erectile dysfunction is associated with lower mortality compared with no treatment for erectile dysfunction after myocardial infarction (MI). There are conflicting results regarding the impact of PDE5i treatment on mortality in conjunction with nitrate medication. OBJECTIVES: The purpose of this study was to investigate the association between PDE5i treatment and cardiovascular outcomes in men with stable coronary artery disease treated with nitrate medication. METHODS: Using the Swedish Patient Register and the Prescribed Drug Register we included men with previous MI or revascularization in 2006-2013 who had 2 dispensed nitrate prescriptions within 6 months. Exposure was defined as at least 2 filled prescriptions of any PDE5i. We performed multivariable Cox proportional hazard regression to estimate HRs with 95% CIs for all-cause, cardiovascular, and noncardiovascular mortality, MI, heart failure, cardiac revascularization, and major cardiovascular events (MACE). RESULTS: In total, 55,777 men were treated with nitrates and 5,710 men with nitrates and a PDE5i. The combined use of PDE5i treatment with nitrates was associated with higher mortality (HR: 1.39; 95% CI: 1.28-1.51), cardiovascular mortality (HR: 1.34; 95% CI: 1.11-1.62), noncardiovascular mortality (HR: 1.40; 95% CI: 1.27-1.54), MI (HR: 1.72; 95% CI: 1.55-1.90), heart failure (HR: 1.67; 95% CI: 1.48-1.90), cardiac revascularization (HR: 1.95; 95% CI: 1.78-2.13), and MACE (HR: 1.70; 95% CI: 1.58-1.83). CONCLUSIONS: The use of a PDE5i in combination with nitrate medication in men with stable coronary artery disease may pose an increased hazard for cardiovascular morbidity and mortality. Careful patient-centered consideration before prescribing PDE5is to patients with cardiovascular disease using nitrate medication is warranted.
Assuntos
Doença da Artéria Coronariana , Disfunção Erétil , Insuficiência Cardíaca , Infarto do Miocárdio , Masculino , Humanos , Inibidores da Fosfodiesterase 5/uso terapêutico , Doença da Artéria Coronariana/complicações , Doença da Artéria Coronariana/tratamento farmacológico , Disfunção Erétil/tratamento farmacológico , Disfunção Erétil/complicações , Nitratos/uso terapêutico , Nucleotídeo Cíclico Fosfodiesterase do Tipo 5/uso terapêutico , Infarto do Miocárdio/tratamento farmacológico , Infarto do Miocárdio/complicações , Insuficiência Cardíaca/tratamento farmacológicoRESUMO
INTRODUCTION AND OBJECTIVES: To investigate the epidemiological characteristics, clinic-pathological findings and recent use of substances of abuse and prescribed drugs in sexual activity-related sudden death (SArSD). METHODS: Multicenter population-based study on forensic autopsies conducted in 27 provinces of Spain over 12 years (2010-2021). RESULTS: Out of 18046 autopsied natural deaths, 64 cases (0.35 %) of SArSD were investigated (87 % males). Women were younger than males (50.5 ± 13.4 years vs 37.2 ± 14.2; p = 0.017). Sudden cardiac deaths (SCD) accounted for 87 % of cases. Ischemic heart disease was the predominant pathology (58 %), mainly affecting men ≥ 36 years of age. Cerebral haemorrhage (8 %) and asthma (5 %) were the leading non-cardiac causes. In young adults, SADS (36 %) and asthma (27 %) were the main causes The disease responsible of SCD was diagnosed in life in 7 subjects. In 64 % there were cardiovascular risk factors, mainly obesity. Toxicological analysis detected illicit drugs (23 %), mainly cocaine, medications for erectile dysfunction (9 %), and ethanol ≥ 0.5 g/L (8 %). Deaths occurred usually in the context of heterosexual intercourse and during or immediately after sexual activity. The most common location was at home (63 %). In 12 men the sexual partner was a sex worker. CONCLUSIONS: SArSD has a low incidence in the general population affecting middle-aged males during intercourse with a heterosexual partner. It is of cardiovascular origin, mainly due to ischemic heart disease that frequently remained silent during life. There is a frequent association with obesity, use of cocaine (and, to a lesser extent, medications for erectile dysfunction) and performing unconventional sexual practices. Forensic investigation is useful for developing prevention strategies.
Assuntos
Asma , Cocaína , Disfunção Erétil , Isquemia Miocárdica , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Humanos , Feminino , Disfunção Erétil/complicações , Comportamento Sexual , Morte Súbita Cardíaca/epidemiologia , Morte Súbita Cardíaca/etiologia , Morte Súbita Cardíaca/patologia , Autopsia , Obesidade/complicações , Causas de MorteAssuntos
Humanos , Masculino , Pessoa de Meia-Idade , Hipogonadismo/diagnóstico , Disfunção Erétil/complicações , Disfunção Erétil/fisiopatologia , Testosterona/sangue , Ereção Peniana , Citrato de Sildenafila/administração & dosagem , Hipogonadismo/etiologia , Disfunção Erétil/tratamento farmacológico , Obesidade/complicaçõesRESUMO
Resumo Objetivo: Investigar, na literatura, intervenções de enfermagem para promover continência urinária e adaptação à disfunção sexual após prostatectomia radical. Métodos: Revisão integrativa da literatura nas bases de dados PubMed, Web of Science, Scopus, CINAHL, e LILACS, utilizando os descritores "cuidados de enfermagem", "incontinência urinária", "disfunção erétil", e "prostatectomia" e as palavras chaves "enf*", "impotência sexual masculina" e "prostatectomia radical". Resultados: Dezoito publicações foram incluídas, entre essas, oito descreviam intervenções para a incontinência urinária, cinco para disfunção sexual e cinco para ambas as complicações. Foram encontradas três estratégias para implementação das intervenções, 16 intervenções para incontinência e 12 para disfunção sexual. Conclusão: Nas estratégias para implementação das intervenções, notou-se a importância de que o enfermeiro utilize diferentes recursos para assistir os pacientes. Para a incontinência urinária, o foco das intervenções variou entre educativo, comportamental e físico. Para disfunção sexual, observou-se um predomínio de ações psicoeducativas aos pacientes e, quando possível, ao parceiro sexual.
Resumen Objetivo: Investigar, en la literatura, intervenciones de enfermería para promover continencia urinaria y adaptación a la disfunción sexual después de prostatectomía radical. Métodos: Revisión integrativa de la literatura en las bases de datos PubMed, Web of Science, Scopus, CINAHL, y LILACS, utilizando los descriptores "cuidados de enfermería", "incontinencia urinaria", "disfunción eréctil", y "prostatectomía" y las palabras claves "enf *", "impotencia sexual masculina" y "prostatectomía radical". Resultados: Dieciocho publicaciones fueron incluidas; entre ellas, ocho describían intervenciones para la incontinencia urinaria, cinco para disfunción sexual y cinco para ambas complicaciones. Se encontraron tres estrategias para la implementación de intervenciones, 16 intervenciones para incontinencia y 12 para disfunción sexual. Conclusão: En las estrategias para la implementación de las intervenciones, se notó la importancia de que el enfermero utilice diferentes recursos para asistir a los pacientes. Para la incontinencia urinaria, el foco de las intervenciones varió entre educativo, conductual y físico. Para la disfunción sexual, se observó un predominio de acciones psicoeducativas junto a los pacientes y, siempre que posible, junto al compañero sexual.
Abstract Objective: Investigate, in the literature, nursing interventions to promote urinary continence and adapt to sexual dysfunction after radical prostatectomy. Methods: Integrative literature review in the databases PubMed, Web of Science, Scopus, CINAHL, and LILACS, using the descriptors "nursing care", "urinary incontinence", "erectile dysfunction", and "prostatectomy", and the keywords "nurse", "male sexual impotence" and "radical prostatectomy". Results: Eighteen publications were included, eight of which described interventions for urinary incontinence, five for sexual dysfunction and five for both complications. Three intervention strategies were found: 16 interventions for incontinence and 12 for sexual dysfunction. Conclusion: In the implementation strategies of interventions, the importance of nurses using different resources to attend to patients was observed. For urinary incontinence, the focus of interventions varied among educational, behavioral and physical. For sexual dysfunction, a predominance of psychoeducational actions was observed, involving the patients and, when possible the sexual partners.
Assuntos
Humanos , Masculino , Prostatectomia , Disfunções Sexuais Fisiológicas/complicações , Incontinência Urinária/complicações , Educação de Pacientes como Assunto , Disfunção Erétil/complicações , Cuidados de EnfermagemRESUMO
OBJECTIVES: To assess the prevalence and interrelationship between lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis (MS). METHODS: In a cross-sectional study, we evaluated 41 men (mean age 41.1±9.9 years) with MS from February 2011 to March 2013, who were invited to participate irrespective of the presence of lower urinary tract symptoms or sexual dysfunction. Neurological impairment was assessed with the Expanded Disability Status Scale; lower urinary tract symptoms were evaluated with the International Continence Society male short-form questionnaire, and sexual dysfunction was evaluated with the International Index of Erectile Function. All patients underwent transabdominal urinary tract sonography and urine culture. RESULTS: The mean disease duration was 10.5±7.3 years. Neurological evaluation showed a median Expanded Disability Status Scale score of 3 [2-6]. The median International Continence Society male short-form questionnaire score was 17 [10-25]. The median International Index of Erectile Function score was 29 [15-46]. Twenty-nine patients (74.4%) had sexual dysfunction as defined by an International Index of Erectile Function score <45. Voiding dysfunction and sexual dysfunction increased with the degree of neurological impairment (r=0.02 [0.02 to 0.36] p=0.03 and r=-0.41 [-0.65 to -0.11] p=0.008, respectively). Lower urinary tract symptoms and sexual dysfunction also displayed a significant correlation (r=-0.31 [-0.56 to -0.01] p=0.04). CONCLUSIONS: Most male patients with MS have lower urinary tract symptoms and sexual dysfunction. The severity of the neurological disease is a predictive factor for the occurrence of voiding and sexual dysfunctions.
Assuntos
Humanos , Masculino , Adulto , Pessoa de Meia-Idade , Idoso , Adulto Jovem , Disfunções Sexuais Fisiológicas/epidemiologia , Sintomas do Trato Urinário Inferior/epidemiologia , Esclerose Múltipla/epidemiologia , Qualidade de Vida , Disfunções Sexuais Fisiológicas/complicações , Disfunções Sexuais Fisiológicas/diagnóstico , Índice de Gravidade de Doença , Brasil/epidemiologia , Prevalência , Estudos Transversais , Inquéritos e Questionários , Bexiga Urinária Hiperativa/complicações , Sintomas do Trato Urinário Inferior/complicações , Sintomas do Trato Urinário Inferior/diagnóstico , Disfunção Erétil/complicações , Esclerose Múltipla/complicações , Esclerose Múltipla/diagnósticoRESUMO
Fundamentos: A disfunção erétil (DE) e a doença arterial coronariana (DAC) compartilham os mesmos fatores de risco e as associações entre DE, qualidade de vida (QV) e DAC têm sido motivo de estudos recentes. Objetivo: Avaliar se a DE está associada a piora da QV em pacientes com DAC. Métodos: Estudo transversal, multicêntrico, prospectivo e analítico, realizado de dezembro de 2014 a abril de 2016, que recrutou 304 homens (idade média: 57 ± 9,9 anos) com diagnóstico clínico de DAC. A QV foi avaliada através do Short Form-36 e a DE pelo Índice Internacional de Função Erétil. Foram realizadas análises estatísticas descritiva e analítica, sendo que o teste não paramétrico Kruskal-Wallis foi usado para analisar se existem diferenças significativas em cada domínio de qualidade de vida quando se comparam os diferentes tipos de DE. Para todos os testes, valor de p ≤ 0,05 foi considerado significante. Resultados: A prevalência de DE foi de 76,3%. As medianas e percentis 25 e 75 de cada domínio de qualidade de vida de acordo com a ausência de DE, DE leve, leve a moderada, moderada e grave, respectivamente, foram: Capacidade funcional: 85 (63-100), 75 (50-95), 60 (32-85), 55 (35-75), 50 (30-70), p < 0,001; Aspectos físicos: 87 (0-100), 40 (0-100), 0 (0-100), 0 (0-31), 0 (0-12), p < 0,001; Dor: 72 (51-100), 66 (51-100), 74 (51-100), 62 (51-100), 51 (31-62), p = 0,001; Estado geral de saúde: 77 (62-87), 72 (57-77), 67 (55-82), 67 (59-75), 52 (37-68), p < 0,001; Vitalidade: 75 (60-85), 65 (50-75), 65 (55-75), 60 (43-75), 50 (32-65), p < 0,001; Aspectos sociais: 87 (62-100), 87 (62-100), 87 (68-100), 75 (62-100), 75 (50-93), p = 0,139; Aspectos emocionais: 100 (58-100), 100 (33-100), 100 (33-100), 100 (0-100), 0 (0-100), p = 0,001; Saúde mental: 80 (67-89), 72 (60-84), 72 (66-80), 68 (58-80), 56 (50-74), p < 0,001. Conclusões: A prevalência de disfunção erétil foi elevada. A DE esteve associada a piora da QV em pacientes com DAC
Background: Erectile dysfunction (ED) and coronary artery disease (CAD) share the same risk factors and the associations between ED, quality of life (QoL) and CAD have been the subject of recent studies. Objective: To evaluate whether ED is associated with worsening QoL in patients with CAD. Methods:A cross-sectional, multicenter, prospective and analytic study was carried out from EDcember 2014 to April 2016, which recruited 304 men (mean age: 57 ± 9.9 years) with clinical diagnosis of CAD. QoL was assessed using Short Form-36 and ED by the International Erectile Function InEDx. EDscriptive and analytical statistical analyzes were performed, and the Kruskal-Wallis non-parametric test was used to test whether there are significant differences in each quality of life domain when comparing different types of ED. For all tests, p ≤ 0.05 was consiEDred significant. Results: The prevalence of ED was 76.3%. The median and percentiles 25 and 75 of each life quality domain according to the absence of ED; mild ED, mild to moderate, moderate and severe ED and severe ED, respectively, were: Functional capacity: 85 (63-100), 75 (50 -95), 60 (32-85), 55 (35-75), 50 (30-70), p < 0.001; Physical aspects: 87 (0-100), 40 (0-100), 0 (0-100), 0 (0-31), 0 (0-12), p < 0.001; Pain: 72 (51-100), 66 (51-100), 74 (51-100), 62 (51-100), 51 (31-62), p = 0.001; General state of health: 77 (62-87), 72 (57-77), 67 (55-82), 67(59-75), 52 (37-68), p < 0.001; Vitality: 75 (60-85), 65 (50-75), 65 (55-75), 60 (43-75), 50 (32-65), p < 0.001; Social Aspects: 87 (62-100), 87 (62-100), 87 (68-100), 75 (62-100), 75 (50-93), p = 0.139; Emotional Aspects: 100 (58-100), 100 (33-100), 100 (33-100), 100 (0-100), 0 (0-100), p = 0.001; Mental health: 80 (67-89), 72 (60-84), 72 (66-80), 68 (58-80), 56 (50-74), p < 0.001. Conclusions: The prevalence of erectile dysfunction was high. ED was associated with worsening of QoL in patients with CAD
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Doença da Artéria Coronariana/fisiopatologia , Disfunção Erétil/complicações , Pacientes , Qualidade de Vida , Fatores de Risco , Fatores Etários , Doenças Cardiovasculares/fisiopatologia , Diagnóstico Clínico/diagnóstico , Angiografia Coronária/métodos , Estudos Transversais , Análise Fatorial , Homens , Prevalência , Fatores Sexuais , Fatores Socioeconômicos , Inquéritos e Questionários , Centros de Atenção TerciáriaRESUMO
Abstract Introduction: Endovascular aneurysm repair (EVAR) is the therapy of choice in high risk patients with abdominal aortic aneurysm. The good results described are leading to the broadening of clinical indications to younger patients. However, reintervention rates seem higher and even with successful treatment sometimes there is growth of the aneurysm sac and rupture, meaning a failure of the therapeutic goal. This study proposes to analyse the impact of age in patients' selection and post-EVAR results. Methods: The clinical records of consecutive patients undergoing endovascular aneurysm repair, between 2001 and 2013, were retrospectively reviewed. Patients were divided according to age groups (<70, 70-80 and >80 years). Gender, body mass index, aneurysm anatomic features, neck characteristics, iliac morphology, surgical indication, endograft type, anesthesic risk classification, length of stay, reinterventions and mortality were analysed and compared. Results: The study included 171 patients, 161 (94.1%) men, and mean age 74.1±8.9 years. The age group under 70 had 32% of the patients. Only three characteristics were found different among age groups: 1) body mass index was higher in younger patients, with a considerable trend toward significance (P=0.06); 2) surgical indication, in the younger group, surgeon's and the patient's option were more proeminent (P<0.05); 3) erectile dysfunction was higher in elderly group (P<0.05). No other clinical and anatomical characteristics or final outcomes were found statisticaly different among age groups. Conclusion: The absence of statistically differences in mortality and reinterventions among age groups suggests that age by itself is not a relevant factor in endovascular aneurysm repair. Indeed, the three characteristics different in younger (obesity, sexual function and patient's choice) favor endovascular aneurysm repair.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Fatores Etários , Aneurisma Ilíaco/cirurgia , Aneurisma da Aorta Abdominal/cirurgia , Seleção de Pacientes , Procedimentos Endovasculares/métodos , Período Pós-Operatório , Índice de Massa Corporal , Estudos Retrospectivos , Resultado do Tratamento , Aneurisma Ilíaco/complicações , Aneurisma Ilíaco/mortalidade , Aneurisma da Aorta Abdominal/complicações , Procedimentos Endovasculares/economia , Disfunção Erétil/complicaçõesRESUMO
Introduction The correlation between erectile dysfunction (ED) and coronary artery disease has been emphasized and ED has been recognized as a potential independent risk factor and/or predictor of coronary artery disease (CAD). We evaluated the association between the number of occluded coronary arteries in myocardial infarction (MI) patients with the severity of ED, and investigated the influence of related risk factors in our study group. Materials and Methods 183 male patients who underwent coronary angiography because of acute MI from November 2009 to May 2011 were included. Following the stabilization of patients after the treatment, each patient was evaluated for erectile functionality. Risk factors such as age, diabetes, smoking, waist circumference, hypertension, and hematologic parameters were recorded. Results Among 183 patients with a mean age of 55.2 years who underwent coronary angiography due to acute MI, 100 (54.64%) had ED, while the ED rate was 45.36% (44/97) in cases of single-vessel disease, 64.5% (31/48) in cases of two-vessel disease, and 65.7% (25/38) in cases of three-vessel disease. The mean IIEF score was 24.2 ± 4.3, 20.4 ± 4.9 and 20.5 ± 4.2 for single or two or three-vessel disease, respectively. The presence of hypertension aggravated ED only in patients with three-vessel disease and increased total and LDL cholesterol levels in patients with single-vessel or two-vessel disease were accompanied by significantly decreasing IIEF scores. Conclusion The severity of ED correlated with the number of occluded vessels documented by coronary angiography, in male patients with acute myocardial infarction. In addition, the presence of hypertension had a significant influence over erectile function only in patients with three-vessel occlusion. .
Assuntos
Adulto , Idoso , Humanos , Masculino , Pessoa de Meia-Idade , Doença da Artéria Coronariana/complicações , Disfunção Erétil/complicações , Infarto do Miocárdio/complicações , Índice de Gravidade de Doença , Distribuição por Idade , Angiografia Coronária , Doença da Artéria Coronariana/epidemiologia , Oclusão Coronária , Disfunção Erétil/epidemiologia , Hipertensão/complicações , Hipertensão/epidemiologia , Infarto do Miocárdio/epidemiologia , Fatores de Risco , Estatísticas não Paramétricas , Circunferência da CinturaRESUMO
FUNDAMENTO: A Disfunção Erétil (DE) se associa ao risco aumentado de Doença Arterial Coronariana (DAC). OBJETIVO: Avaliar a associação entre DE, determinada pelo Índice Internacional de Função Erétil Simplificado (IIFE-5), e DAC. MÉTODOS: Estudo de corte transversal que avaliou 263 hipertensos (55 [50 - 61] anos). A DE foi avaliada pelo IIEF-5 e a DAC, por meio da história de revascularização miocárdica prévia e/ou por cineangiocoronariografia. RESULTADOS: O IIFE-5 se correlacionou com o clearance de creatinina [ClCr] (Rho = 0,23; p < 0,001) e com a idade (Rho = -0,22; p < 0,001). Quarenta e dois pacientes apresentavam DAC; e o IIFE-5 foi capaz de discriminá-los (área sob a curva ROC = 0,63; p = 0,006). Os pacientes foram divididos em dois grupos: IIFE-5 < 20 (n = 140) e IIFE- 5 > 20 (n = 123); aqueles com menor IIFE-5 tinham idade mais elevada (57 [52 - 61] vs. 54 [45 - 60] anos; p = 0,002), maior prevalência de DAC (22% vs. 9%; p = 0,004), tabagismo (64% vs. 47%; p = 0,009) e do uso de inibidores dos canais de cálcio (65 % vs. 43%; p = 0,001), além de menor ClCr (67,3 [30,8 - 88,6] vs. 82,6 [65,9 - 98,2] ml/min; p < 0,001). O IIFE-5 < 20 se associou ao maior risco de DAC em regressão logística; tanto univariada (RR = 2,89 [IC 95% 1,39 - 6,05]), quanto após ajustes para idade, diabetes, ClCr, tabagismo, pressão arterial média e uso de anti- hipertensivos (RR = 2,59 [IC 95%: 1,01 - 6,61]). CONCLUSÃO: O IIFE-5 se associa ao diagnóstico de DAC e sua utilização pode agregar informação ao estadiamento do risco cardiovascular em pacientes hipertensos.
BACKGROUND: Erectile Dysfunction (ED) is associated with increased risk of coronary artery disease (CAD). OBJECTIVE: To evaluate the association between ED, determined by the Simplified International Index of Erectile Function (IIEF-5) and CAD. METHODS: This was a cross-sectional cohort study that evaluated 263 hypertensive patients (55 [50-61] years). ED was assessed through the IIEF-5 and CAD by the history of previous myocardial revascularization and/or coronary angiography. RESULTS: The IIEF-5 correlated with creatinine clearance [CrCl] (Rho = 0.23, p <0.001) and age (Rho = -0.22, p <0.001). Forty-two patients had CAD, and IIEF-5 was able to discriminate them (area under the ROC curve = 0.63, p = 0.006). Patients were divided into two groups: IIEF-5 < 20 (n = 140) and IIEF-5 > 20 (n = 123); those with lower IIEF-5 scores were older (57 [52-61] vs. 54 [45-60] years, p = 0.002), had higher prevalence of CAD (22% vs. 9%, p = 0.004), smoking (64% vs. 47%, p = 0.009) and use of calcium channel inhibitors (65% vs. 43.%, p = 0.001), as well as lower CrCl (67.3 [30.8 to 88.6] vs. 82.6 [65.9 - 98.2] ml/min, p <0.001). The IIEF-5 < 21 was associated with increased risk of CAD in the logistic regression, both univariate (RR = 2.89 [95%CI: 1.39 - 6.05]), and after adjusting for age, diabetes, CrCl, smoking, mean arterial pressure and use of antihypertensive drugs (RR = 2.59 [95% CI: 1.01 - 6.61]). CONCLUSION: The IIEF-5 is associated with the diagnosis of CAD and its use can add information to cardiovascular risk staging in hypertensive patients.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Doença da Artéria Coronariana/etiologia , Disfunção Erétil/complicações , Hipertensão/sangue , Pressão Sanguínea/fisiologia , Doença da Artéria Coronariana/sangue , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/fisiopatologia , Métodos Epidemiológicos , Disfunção Erétil/sangue , Disfunção Erétil/fisiopatologia , Hipertensão/fisiopatologia , Fatores de Risco , Índice de Gravidade de DoençaRESUMO
Las funciones sexuales y eréctiles son importantes en la salud de los hombres y el bienestar de las parejas. La disfunción eréctil (DE) tiene una alta prevalencia fundamentalmente en las últimas décadas de la vida y se halla relacionada con múltiples factores de riesgo. Objetivo: establecer algunos factores de riesgo y enfermedades concomitantes así como la prevalencia de la disfunción eréctil en la población masculina mayor de 35 años de la ciudad de Siguatepeque, Honduras, agosto del 2009. Metodología; estudio descriptivo de corte transversal. La población fue de 5,200 hombres mayores de 35 años. La muestra de 371 hombres. El método de muestreo fue estratificado según barrios de la ciudad. La unidad de estudio fue seleccionada en forma aleatoria. Para la recolección de datos se utilizaron dos instrumentos, una encuesta con datos de carácter general; otro instrumento utilizado fue el Test de SHIM (Sexual Health Inventory for Men), cuestionario sobre salud sexual masculina, versión abreviada del IIEF (Índice Internacional de Función Eréctil) del que se seleccionaron 5 preguntas sobre sexualidad masculina en los últimos 6 meses, con el propósito de detectar DE en grupos de riesgo. Se considera DE cuando la puntuación es igual o inferior a 21. Resultados; La prevalencia de DE encontrada fue de 214(58%) del total de la muestra, los grados de disfunción fueron: Leve 114(53%), de Leve a Moderada 57(27%), Moderada 18(8%), y Grave 25(12%). La DE encontrada según rangos de edad fue para mayores de 60 años 94(44%), de 45 a 59 años 95(45%), de 35 a 44 años 25(11%). Los hábitos tóxicos: hombres que en el pasado ingirieron bebidas alcohólicas y al momento de la entrevista consumían y tenían DE 104(49%) y 50(23%) respectivamente. Tabaquismo como antecedente de consumo y al momento de la entrevista presentaban DE, 96(45%) y 55(26%) respectivamente. El consumo de otras drogas 3(1%). Las enfermedades concomitantes que se relacionan con DE fueron: problemas cardiovascular...
Assuntos
Humanos , Masculino , Adulto , Disfunção Erétil/complicações , Disfunções Sexuais Fisiológicas/diagnóstico , Induração Peniana/complicações , Alcoolismo/complicações , Coleta de Dados/métodosRESUMO
A disfunção erétil tem fatores de risco similares aos das doenças cardiovasculares, mas também pode ser um fator de risco independente para tais doenças. As evidências atuais consideram a disfunção erétil como uma desordem primordialmente de origem vascular e, mais do que isso, como um marcador precoce das doenças cardiovasculares. Apesar disso, o potencial da disfunção erétil como um sinal para alertar os médicos para uma possível manifestação precoce de doenças cardiovasculares mais graves tem sido pouco explorado na prática clínica diária.
Assuntos
Humanos , Masculino , Complicações do Diabetes/complicações , Células Endoteliais/metabolismo , Células Endoteliais/patologia , Disfunção Erétil/complicações , Disfunção Erétil/epidemiologia , Disfunção Erétil/patologia , Dislipidemias/complicações , Obesidade/complicações , Tabagismo/efeitos adversos , Óxido Nítrico/metabolismo , Saúde do HomemRESUMO
During the last 15 years there has been increasing evidence demonstrating that erectile dysfunction (ED) due to vascular etiology is a primary manifestation of endothelial damage and that in a high percentage of the affected men it precedes coronary artery disease (CAD). These findings have positionated ED as a significant risk factor for CAD. The association between these pathological entities relies mainly in anatomical factor since the diameter of the cavernosal arteries is 1 to 2 mm and of the coronary arteries 3 to 4 mm. Considering that the physiopathology of the endothelial dysfunction is the same in both diseases, the clinical manifestations (DE) become apparent first in the organ with the smaller arteries. Classically the vascular study of the penis has been done with the color doppler ultrasound of the cavernosal arteries associated with an injection of prostaglandin E2; in the clinical setting this study represents a penile stress test (functional study). A pathological result in the color doppler ultrasound of the cavernosal arteries in patients with DE predicts the presence of CAD with high accuracy. Taking this information in account the specific study of these blood vessels may allow the detection of patients in risk of having CAD, positionating this study as a screnning method for patients in cardiovascular risk.
Assuntos
Humanos , Masculino , Disfunção Erétil/complicações , Disfunção Erétil/diagnóstico , Doença das Coronárias/complicações , Doença das Coronárias/diagnóstico , Disfunção Erétil/etiologia , Previsões , Fatores de RiscoRESUMO
The term biological clock is usually used by physicians and psychologists to refer to the declining fertility, increasing risk of fetal birth defects and alterations to hormone levels experienced by women as they age. Female fecundity declines slowly after the age of 30 years and more rapidly after 40 and is considered the main limiting factor in treating infertility. However, there are several scientific reports, chapters in books and review articles suggesting that men may also have a biological clock. The aim of our study was to conduct a review of the literature, based on the Medical Literature Analysis and Retrieval System Online (Medline), to evaluate the male biological clock. After adjustments for other factors, the data demonstrate that the likelihood that a fertile couple will take more than 12 months to conceive nearly doubles from 8 percent when the man is < 25 years old to 15 percent when he is > 35 years old. Thus, paternal age is a further factor to be taken into account when deciding on the prognosis for infertile couples. Also, increasing male age is associated with a significant decline in fertility (five times longer to achieve pregnancy at the age of 45 years). Patients and their physicians therefore need to understand the effects of the male biological clock on sexual and reproductive health, in that it leads to erectile dysfunction and male infertility, as well as its potential implications for important medical conditions such as diabetes and cardiovascular diseases.
O termo relógio biológico é geralmente usado por médicos e psicólogos para se referir ao declínio da fertilidade, aumento no risco de defeitos congênitos, e níveis hormonais alterados que a mulher com o passar dos anos apresenta. A fecundidade feminina declina paulatinamente após os 30 anos e mais rapidamente após os 40 anos e é considerada como o principal fator limitante nos tratamentos da infertilidade. Entretanto, existem vários artigos científicos capítulos de livros e artigos de revisão sugerindo que o homem também apresente um relógio biológico. O objetivo do nosso estudo foi realizar uma revisão no Medline (Medical Literature Analysis and Retrieval System Online) para avaliar o relógio biológico masculino. Após ajustar para outros fatores, foi demonstrado que a probabilidade de um casal apresentar uma demora superior a 12 meses para engravidar praticamente duplica de 8 por cento quando o homem possui idade inferior a 25 para 15 por cento quando possui idade superior a 35 anos; desta forma, a idade paterna é um fator a ser levado em consideração quando se decidir sobre o prognóstico de um casal infértil. Além disso, a idade avançada está associada com um declínio significante na fertilidade (tempo para engravidar superior a cinco vezes aos 45 anos de idade), sendo independente de idade da parceira, freqüência de relação sexual e estilo de vida, assim como os efeitos de outros fatores de risco para subfertilidade. Os pacientes e seus médicos devem entender os efeitos do relógio biológico na saúde sexual e reprodutiva, levado à disfunção erétil e infertilidade, assim como às potenciais contribuições para condições médicas como diabetes e doenças cardiovasculares.